Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Nuo Therapeutics, Inc. | v314075_8k.htm |
CYTOMEDIX, INC.
CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION
| l. | The name of the corporation (hereinafter called the “Corporation”) is |
Cytomedix, Inc.
| 2. | The Corporation desires to increase the number of authorized shares of common stock from 100,000,000 to 160,000,000 and the number of authorized shares of capital stock from 115,000,000 to 175,000,000. |
| 3. | The Board of Directors of the Corporation duly adopted resolutions setting forth a proposed amendment to the Certificate of Incorporation, as amended to date, declaring said amendment advisable and calling a meeting of the shareholders of the Corporation for consideration thereof. The resolution setting the proposed amendment as follows: |
RESOLVED, that the first sentence in article Four of the Certificate of Incorporation is amended and restated to read in its entirety as follows:
“The authorized capital stock of the Corporation shall consist of 175,000,000 shares of capital stock, of which 160,000,000 shares shall be Common Stock, with a par value of $.0001 per share, and 15,000,000 shares shall be Preferred Stock, with a par value of $.0001 per share.”
The remaining paragraphs of article Four shall remain unchanged.
| 4. | The amendment herein certified has been duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware. |
| 5. | The amendment is effective on the date of filing of this Certificate with the Secretary of State of the State of Delaware. |
IN WITNESS WHEREOF, the undersigned has signed this Certificate of Amendment as of this May 18, 2012.
| CYTOMEDIX, INC. | |
| By: /s/ Andrew Maslan | |
| Name: Andrew Maslan | |
| Title: Chief Financial Officer, Secretary |